Blood Recirculation Enhances Oxygenation Efficiency of Artificial Lungs

被引:11
作者
Madhani, Shalv P. [1 ,2 ]
May, Alexandra G. [1 ,3 ]
Frankowski, Brian J. [1 ,2 ]
Burgreen, Greg W. [4 ]
Federspiel, William J. [1 ,2 ,3 ,5 ]
机构
[1] Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA
[2] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15203 USA
[3] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15203 USA
[4] Mississippi State Univ, Ctr Adv Vehicular Syst, Computat Fluid Dynam Grp, Starkville, MS USA
[5] Univ Pittsburgh, Dept Crit Care Med, Med Ctr, Pittsburgh, PA 15203 USA
基金
美国国家卫生研究院;
关键词
Wearable ECMO; Ambulation; Recirculation; CARBON-DIOXIDE REMOVAL; CO2; REMOVAL; IN-VITRO; PUMP-LUNG; 6; ML/KG; EXTRACORPOREAL; TRANSPLANTATION; MOBILIZATION; DESIGN; MODEL;
D O I
10.1097/MAT.0000000000001030
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Ambulating patients on extracorporeal membrane oxygenation (ECMO) or extracorporeal CO2 removal (ECCO2R) improves outcomes. These systems would further simplify ambulation if made more compact. This study investigates blood recirculation to decrease device size by increasing efficiency. The required hollow fiber membrane (HFM) area was determined by numerically modeling gas transfer. An oxygenation device with recirculating blood flow was designed using computational fluid dynamics (CFD). Hydrodynamic performance and shear stresses of the device were analyzed using CFD at 2,000, 2,250 and 2,500 RPM. A prototype (0.38 m(2)) was manufactured for in-vitro oxygenation testing. Oxygenation was measured at a constant 3.5 L/min blood flow while recirculation flow rate varied up to 6.5 L/min. Hemolysis was measured at 3.5 L/min blood flow and 6.5 L/min recirculation flow. A 0.3 m(2) prototype device was used to test in-vitro ECCO2R recirculation at a constant 500 ml/min blood flow rate and recirculation flow rates up to 5.5 L/min. Computational fluid dynamics analysis showed that the oxygenation device could produce over 250 mm Hg while maintaining 3.5 L/min blood flow and 6.5 L/min recirculation flow. The model predicted oxygenation within 8% and overestimated ECCO2R by up to 32%. Measured gas transfer was 180 ml O-2/min and 62 ml CO2/min. Normalized index of hemolysis contribution of the HFM was 0.012 gm/100 L.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 30 条
[1]  
Abrams Darryl C, 2013, Ann Am Thorac Soc, V10, P307, DOI 10.1513/AnnalsATS.201301-021OC
[2]  
Akkanti Bindu, 2017, J Extra Corpor Technol, V49, P112
[3]   Carbon dioxide transport [J].
Arthurs, G. J. ;
Sudhakar, M. .
BJA EDUCATION, 2005, 5 (06) :207-210
[4]   Lower tidal volume strategy (≈ 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS [J].
Bein, Thomas ;
Weber-Carstens, Steffen ;
Goldmann, Anton ;
Mueller, Thomas ;
Staudinger, Thomas ;
Brederlau, Joerg ;
Muellenbach, Ralf ;
Dembinski, Rolf ;
Graf, Bernhard M. ;
Wewalka, Marlene ;
Philipp, Alois ;
Wernecke, Klaus-Dieter ;
Lubnow, Matthias ;
Slutsky, Arthur S. .
INTENSIVE CARE MEDICINE, 2013, 39 (05) :847-856
[5]   Awake Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation: A 9-Year Experience [J].
Biscotti, Mauer ;
Gannon, Whitney D. ;
Agerstrand, Cara ;
Abrams, Darryl ;
Sonett, Joshua ;
Brodie, Daniel ;
Bacchetta, Matthew .
ANNALS OF THORACIC SURGERY, 2017, 104 (02) :412-419
[6]   ECMO as Bridge to Lung Transplant [J].
Biscotti, Mauer ;
Sonett, Joshua ;
Bacchetta, Matthew .
THORACIC SURGERY CLINICS, 2015, 25 (01) :17-+
[7]   The "Sport Model": Extracorporeal Membrane Oxygenation Using the Subclavian Artery [J].
Biscotti, Mauer ;
Bacchetta, Matthew .
ANNALS OF THORACIC SURGERY, 2014, 98 (04) :1487-1489
[8]   Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung [J].
Bonin, Frank ;
Sommerwerck, Urte ;
Lund, Laura W. ;
Teschler, Helmut .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (05) :E43-E44
[9]  
Federspiel W, 2008, ENCY BIOMATER BIOMED, V9, P910
[10]  
Hubbard L, 1994, US Patent, Patent No. [US5411706, 5411706]